第40次放射性药品不良反应调查报告(2017年第43次调查)。

Kaku igaku. The Japanese journal of nuclear medicine Pub Date : 2019-01-01 DOI:10.18893/kakuigaku.rp.1974

Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura

{"title":"第40次放射性药品不良反应调查报告(2017年第43次调查)。","authors":"Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura","doi":"10.18893/kakuigaku.rp.1974","DOIUrl":null,"url":null,"abstract":"This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2017 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 981 institutions among 1,231 to which the questionnaire had been sent. Twelve cases of adverse reactions were reported. A total of 1,028,886 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.2. No case of deficient products was reported.","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[The 40th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 43rd Survey in 2017)].\",\"authors\":\"Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura\",\"doi\":\"10.18893/kakuigaku.rp.1974\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2017 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 981 institutions among 1,231 to which the questionnaire had been sent. Twelve cases of adverse reactions were reported. A total of 1,028,886 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.2. No case of deficient products was reported.\",\"PeriodicalId\":17738,\"journal\":{\"name\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18893/kakuigaku.rp.1974\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kaku igaku. The Japanese journal of nuclear medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18893/kakuigaku.rp.1974","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

本调查旨在调查2017财年日本放射性药物不良反应的发生率。该报告是根据对核医学机构的问卷调查得出的。在收到调查问卷的1,231所院校中，有981所院校作出了答复。报告不良反应12例。共报告了1,028,886次放射性药物管理。不良反应发生率为每10万例1.2例。未发现缺陷产品。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[The 40th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 43rd Survey in 2017)].

This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2017 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 981 institutions among 1,231 to which the questionnaire had been sent. Twelve cases of adverse reactions were reported. A total of 1,028,886 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.2. No case of deficient products was reported.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Kaku igaku. The Japanese journal of nuclear medicine Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： The main scope of JSNM is the appropriate development of the application of radioactive substances and stable nuclides in medicine. Towards this scope, JSNM promotes the exchange of idea and information, and researches in nuclear medicine. JSNM are interested in the international collaboration for the development of nuclear medicine. Through the activities, JSNM contributes to the medicine, as well as humanity, not only in Japan but also in any countries over the world.